Skip to main content
. 2009 Oct 2;4(10):e7287. doi: 10.1371/journal.pone.0007287

Figure 4. Overall survival according to the number of molecular abnormalities within individual tumor samples.

Figure 4

Data from the cohort of patients with a known molecular status of all four markers.